Serum markers of fibrosis, cardiovascular and all-cause mortality in hemodialysis patients: the AURORA trial

BACKGROUND: Biomarkers of fibrosis are associated with outcome in several cardiovascular diseases. However, their relevance to chronic kidney disease and dialysis is uncertain, as it remains unclear how the kidneys and the dialysis procedure itself affect their elimination and degradation. We aimed...

Descripción completa

Detalles Bibliográficos
Autores principales: Salib, Madonna, Girerd, Sophie, Girerd, Nicolas, März, Winfried, Scharnagl, Hubert, Massy, Ziad A., Leroy, Céline, Duarte, Kévin, Holdaas, Hallvard, Jardine, Alan G., Schmieder, Roland E., Fellström, Bengt, López-Andrés, Natalia, Rossignol, Patrick, Zannad, Faiez
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9151553/
https://www.ncbi.nlm.nih.gov/pubmed/34170371
http://dx.doi.org/10.1007/s00392-021-01898-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9151553/
https://www.ncbi.nlm.nih.gov/pubmed/34170371
http://dx.doi.org/10.1007/s00392-021-01898-9

Ejemplares similares